Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 2
1951 1
1962 1
1973 1
1977 3
1978 2
1979 4
1980 4
1981 2
1982 8
1983 2
1984 5
1985 10
1986 3
1987 5
1988 3
1989 6
1990 5
1991 8
1992 4
1993 8
1994 5
1995 4
1996 5
1997 4
1998 7
1999 3
2000 7
2001 3
2002 8
2003 11
2004 5
2005 6
2006 12
2007 11
2008 13
2009 11
2010 8
2011 9
2012 8
2013 7
2014 4
2015 5
2016 6
2017 8
2018 5
2019 4
2020 1
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

253 results
Results by year
Filters applied: . Clear all
Page 1
Vascular Tumors in Infants: Case Report and Review of Clinical, Histopathologic, and Immunohistochemical Characteristics of Infantile Hemangioma, Pyogenic Granuloma, Noninvoluting Congenital Hemangioma, Tufted Angioma, and Kaposiform Hemangioendothelioma.
Johnson EF, Davis DM, Tollefson MM, Fritchie K, Gibson LE. Johnson EF, et al. Am J Dermatopathol. 2018 Apr;40(4):231-239. doi: 10.1097/DAD.0000000000000983. Am J Dermatopathol. 2018. PMID: 29561329 Review.
ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor.
Tse C, Shoemaker AR, Adickes J, Anderson MG, Chen J, Jin S, Johnson EF, Marsh KC, Mitten MJ, Nimmer P, Roberts L, Tahir SK, Xiao Y, Yang X, Zhang H, Fesik S, Rosenberg SH, Elmore SW. Tse C, et al. Among authors: johnson ef. Cancer Res. 2008 May 1;68(9):3421-8. doi: 10.1158/0008-5472.CAN-07-5836. Cancer Res. 2008. PMID: 18451170 Free article.
Navigating the kinome.
Metz JT, Johnson EF, Soni NB, Merta PJ, Kifle L, Hajduk PJ. Metz JT, et al. Among authors: johnson ef. Nat Chem Biol. 2011 Apr;7(4):200-2. doi: 10.1038/nchembio.530. Epub 2011 Feb 20. Nat Chem Biol. 2011. PMID: 21336281
Mechanistic Dissection of PARP1 Trapping and the Impact on In Vivo Tolerability and Efficacy of PARP Inhibitors.
Hopkins TA, Shi Y, Rodriguez LE, Solomon LR, Donawho CK, DiGiammarino EL, Panchal SC, Wilsbacher JL, Gao W, Olson AM, Stolarik DF, Osterling DJ, Johnson EF, Maag D. Hopkins TA, et al. Among authors: johnson ef. Mol Cancer Res. 2015 Nov;13(11):1465-77. doi: 10.1158/1541-7786.MCR-15-0191-T. Epub 2015 Jul 27. Mol Cancer Res. 2015. PMID: 26217019 Free article.
ABT-888, an orally active poly(ADP-ribose) polymerase inhibitor that potentiates DNA-damaging agents in preclinical tumor models.
Donawho CK, Luo Y, Luo Y, Penning TD, Bauch JL, Bouska JJ, Bontcheva-Diaz VD, Cox BF, DeWeese TL, Dillehay LE, Ferguson DC, Ghoreishi-Haack NS, Grimm DR, Guan R, Han EK, Holley-Shanks RR, Hristov B, Idler KB, Jarvis K, Johnson EF, Kleinberg LR, Klinghofer V, Lasko LM, Liu X, Marsh KC, McGonigal TP, Meulbroek JA, Olson AM, Palma JP, Rodriguez LE, Shi Y, Stavropoulos JA, Tsurutani AC, Zhu GD, Rosenberg SH, Giranda VL, Frost DJ. Donawho CK, et al. Among authors: johnson ef. Clin Cancer Res. 2007 May 1;13(9):2728-37. doi: 10.1158/1078-0432.CCR-06-3039. Clin Cancer Res. 2007. PMID: 17473206 Free article.
Investigation of biaryl heterocycles as inhibitors of Wee1 kinase.
Mastracchio A, Lai C, Torrent M, Bromberg K, Buchanan FG, Ferguson D, Bontcheva V, Johnson EF, Lasko L, Maag D, Shoemaker AR, Penning TD. Mastracchio A, et al. Among authors: johnson ef. Bioorg Med Chem Lett. 2019 Jun 15;29(12):1481-1486. doi: 10.1016/j.bmcl.2019.04.017. Epub 2019 Apr 9. Bioorg Med Chem Lett. 2019. PMID: 31014911
253 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page